#Univercells is happy to welcome on board new members to our team!
Rachana, Sanjeev, Laurence, Emeline and Alexandra will reinforce our development and project management departments.Interested in joining our #GreatTeam? Check out our open positions and apply now: https://lnkd.in/gAZSJZY
The cost of biologics impacts both patients and manufacturers. Search for efficacy, facility size & process review can lead to cost-efficiency. Great article from BioPharma-Reporter https://bit.ly/2WPpe6a
"Increasing awareness about global #epidemics and the need for adapted rapid response capabilities (...) are increasing market demand for novel #sustainable and #responsive production models” affirms Pierre A. MORGON PharmD LL.M MBA, member of #Univercells board of directors. Read full article by Genetic Engineering & Biotechnology News on vaccine development and manufacturing
State Visit to Korea comes to an end!
It is such a honor to have the opportunity to participate in such a high-quality event and a privilege to connect with players of the industry committed to positively impact global #healthcare#Biologicsforall#BELKOR2019
#Univercells is honored to join the Belgian State Visit to Korea with Their Majesties King Philippe and Queen Mathilde to strenghten even further #partnerships with Korean players in the #biotech industry.
Click below to read official press release
Global #measles cases increased by 48% between 2017 & 2018. Last year, almost 300,000 global measles cases were reported in 2018. This year the number already exceeds 24,000 cases. Read more about the outbreak